CA2528093A1 - Produits aryl-heteroaromatiques, compositions les contenant et utilisation - Google Patents
Produits aryl-heteroaromatiques, compositions les contenant et utilisation Download PDFInfo
- Publication number
- CA2528093A1 CA2528093A1 CA002528093A CA2528093A CA2528093A1 CA 2528093 A1 CA2528093 A1 CA 2528093A1 CA 002528093 A CA002528093 A CA 002528093A CA 2528093 A CA2528093 A CA 2528093A CA 2528093 A1 CA2528093 A1 CA 2528093A1
- Authority
- CA
- Canada
- Prior art keywords
- phenyl
- piperazin
- methanone
- pyrrol
- imidazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title abstract description 117
- 150000001875 compounds Chemical class 0.000 claims abstract description 25
- 239000003814 drug Substances 0.000 claims abstract description 4
- -1 4- {4- [3- (2-chloro-phenyl) -5-methyl-isoxazole-4-carbonyl] -piperazin-1-yl) -phenyl Chemical group 0.000 claims description 187
- 239000002253 acid Substances 0.000 claims description 70
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims description 36
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 30
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 19
- 125000001072 heteroaryl group Chemical group 0.000 claims description 16
- 229910052736 halogen Inorganic materials 0.000 claims description 15
- 229910052799 carbon Inorganic materials 0.000 claims description 13
- 150000002367 halogens Chemical class 0.000 claims description 13
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 11
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 11
- 102000004243 Tubulin Human genes 0.000 claims description 10
- 108090000704 Tubulin Proteins 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 238000006116 polymerization reaction Methods 0.000 claims description 9
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 8
- 125000000623 heterocyclic group Chemical group 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 125000001424 substituent group Chemical group 0.000 claims description 8
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 7
- 210000004027 cell Anatomy 0.000 claims description 7
- 230000002401 inhibitory effect Effects 0.000 claims description 7
- 230000035755 proliferation Effects 0.000 claims description 7
- 150000003254 radicals Chemical class 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 claims description 5
- JRIMABXHSLDPOY-UHFFFAOYSA-N 3-[4-(4-phenyl-1h-pyrrole-3-carbonyl)piperazin-1-yl]benzonitrile Chemical compound C=1NC=C(C=2C=CC=CC=2)C=1C(=O)N(CC1)CCN1C1=CC=CC(C#N)=C1 JRIMABXHSLDPOY-UHFFFAOYSA-N 0.000 claims description 5
- 125000004076 pyridyl group Chemical group 0.000 claims description 5
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 5
- 125000003107 substituted aryl group Chemical group 0.000 claims description 5
- YEHAFSPUXRGMOF-UHFFFAOYSA-N 3-[4-(3-phenylimidazole-4-carbonyl)piperazin-1-yl]benzonitrile Chemical compound C=1N=CN(C=2C=CC=CC=2)C=1C(=O)N(CC1)CCN1C1=CC=CC(C#N)=C1 YEHAFSPUXRGMOF-UHFFFAOYSA-N 0.000 claims description 4
- HRJGULOIKVEEDQ-UHFFFAOYSA-N 3-[4-(5-phenyl-2-sulfanylidene-1,3-dihydroimidazole-4-carbonyl)piperazin-1-yl]benzonitrile Chemical compound N1C(S)=NC(C=2C=CC=CC=2)=C1C(=O)N(CC1)CCN1C1=CC=CC(C#N)=C1 HRJGULOIKVEEDQ-UHFFFAOYSA-N 0.000 claims description 4
- NSWNHLDZPLNTDC-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-(2-phenyl-1h-pyrrol-3-yl)methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C2=C(NC=C2)C=2C=CC=CC=2)=C1 NSWNHLDZPLNTDC-UHFFFAOYSA-N 0.000 claims description 4
- XVJBGAZNWMPLLF-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-(3-phenyl-1h-pyrrol-2-yl)methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C2=C(C=CN2)C=2C=CC=CC=2)=C1 XVJBGAZNWMPLLF-UHFFFAOYSA-N 0.000 claims description 4
- OAWKLWMJWIMLCV-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-(4-phenyl-1h-pyrrol-3-yl)methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C=2C(=CNC=2)C=2C=CC=CC=2)=C1 OAWKLWMJWIMLCV-UHFFFAOYSA-N 0.000 claims description 4
- MXCRMZHVUFLCCD-UHFFFAOYSA-N [4-(3-chlorophenyl)piperazin-1-yl]-(3-phenyl-1h-pyrrol-2-yl)methanone Chemical compound ClC1=CC=CC(N2CCN(CC2)C(=O)C2=C(C=CN2)C=2C=CC=CC=2)=C1 MXCRMZHVUFLCCD-UHFFFAOYSA-N 0.000 claims description 4
- WKDUJKVNQLAUAQ-UHFFFAOYSA-N [4-[3-(hydroxymethyl)phenyl]piperazin-1-yl]-(2-phenyl-1h-pyrrol-3-yl)methanone Chemical compound OCC1=CC=CC(N2CCN(CC2)C(=O)C2=C(NC=C2)C=2C=CC=CC=2)=C1 WKDUJKVNQLAUAQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- JSQFVFVKZGVANQ-UHFFFAOYSA-N (2-amino-4-phenyl-1,3-thiazol-5-yl)-[4-[3-(hydroxymethyl)phenyl]piperazin-1-yl]methanone Chemical compound S1C(N)=NC(C=2C=CC=CC=2)=C1C(=O)N(CC1)CCN1C1=CC=CC(CO)=C1 JSQFVFVKZGVANQ-UHFFFAOYSA-N 0.000 claims description 3
- IMWLLSZOLWWMTG-UHFFFAOYSA-N (4-phenyl-1h-imidazol-5-yl)-(4-pyridin-3-ylpiperazin-1-yl)methanone Chemical compound N1C=NC(C=2C=CC=CC=2)=C1C(=O)N(CC1)CCN1C1=CC=CN=C1 IMWLLSZOLWWMTG-UHFFFAOYSA-N 0.000 claims description 3
- IISFNCJURYTOGV-UHFFFAOYSA-N 3-[4-(4-phenyl-1h-imidazole-5-carbonyl)piperazin-1-yl]benzonitrile Chemical compound N1C=NC(C=2C=CC=CC=2)=C1C(=O)N(CC1)CCN1C1=CC=CC(C#N)=C1 IISFNCJURYTOGV-UHFFFAOYSA-N 0.000 claims description 3
- 206010028980 Neoplasm Diseases 0.000 claims description 3
- AAKVKMQATUOQAK-UHFFFAOYSA-N [2-(4-chlorophenyl)furan-3-yl]-[4-(3-methoxyphenyl)piperazin-1-yl]methanone Chemical compound COC1=CC=CC(N2CCN(CC2)C(=O)C2=C(OC=C2)C=2C=CC(Cl)=CC=2)=C1 AAKVKMQATUOQAK-UHFFFAOYSA-N 0.000 claims description 3
- WQLGNVRHIMLWDT-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-(2-methyl-4-phenyl-1,3-thiazol-5-yl)methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C2=C(N=C(C)S2)C=2C=CC=CC=2)=C1 WQLGNVRHIMLWDT-UHFFFAOYSA-N 0.000 claims description 3
- LCSQNNICYSIJIG-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-[1-(2-hydroxyethyl)-2-phenylpyrrol-3-yl]methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C2=C(N(CCO)C=C2)C=2C=CC=CC=2)=C1 LCSQNNICYSIJIG-UHFFFAOYSA-N 0.000 claims description 3
- LRBHFVPAJZCNQL-UHFFFAOYSA-N [4-(3,5-dimethylphenyl)piperazin-1-yl]-[2-(2-methoxyethylamino)-4-phenyl-1,3-thiazol-5-yl]methanone Chemical compound S1C(NCCOC)=NC(C=2C=CC=CC=2)=C1C(=O)N(CC1)CCN1C1=CC(C)=CC(C)=C1 LRBHFVPAJZCNQL-UHFFFAOYSA-N 0.000 claims description 3
- XEGWLHUDVLKYJU-UHFFFAOYSA-N [4-(3-chlorophenyl)piperazin-1-yl]-(2-phenyl-1h-pyrrol-3-yl)methanone Chemical compound ClC1=CC=CC(N2CCN(CC2)C(=O)C2=C(NC=C2)C=2C=CC=CC=2)=C1 XEGWLHUDVLKYJU-UHFFFAOYSA-N 0.000 claims description 3
- WELRZMGYQBXTOR-UHFFFAOYSA-N [4-(3-chlorophenyl)piperazin-1-yl]-(3-phenylthiophen-2-yl)methanone Chemical compound ClC1=CC=CC(N2CCN(CC2)C(=O)C2=C(C=CS2)C=2C=CC=CC=2)=C1 WELRZMGYQBXTOR-UHFFFAOYSA-N 0.000 claims description 3
- DSABEFXPCZJARP-UHFFFAOYSA-N [4-(3-chlorophenyl)piperazin-1-yl]-(4-phenyl-1h-pyrrol-3-yl)methanone Chemical compound ClC1=CC=CC(N2CCN(CC2)C(=O)C=2C(=CNC=2)C=2C=CC=CC=2)=C1 DSABEFXPCZJARP-UHFFFAOYSA-N 0.000 claims description 3
- SGMKXOIIRHQVMG-UHFFFAOYSA-N [4-(3-methoxyphenyl)piperazin-1-yl]-(4-phenyl-1h-imidazol-5-yl)methanone Chemical compound COC1=CC=CC(N2CCN(CC2)C(=O)C2=C(N=CN2)C=2C=CC=CC=2)=C1 SGMKXOIIRHQVMG-UHFFFAOYSA-N 0.000 claims description 3
- SVWOOCWFNNIZDA-UHFFFAOYSA-N [4-[3-(hydroxymethyl)phenyl]piperazin-1-yl]-(4-phenyl-1h-imidazol-5-yl)methanone Chemical compound OCC1=CC=CC(N2CCN(CC2)C(=O)C2=C(N=CN2)C=2C=CC=CC=2)=C1 SVWOOCWFNNIZDA-UHFFFAOYSA-N 0.000 claims description 3
- 201000011510 cancer Diseases 0.000 claims description 3
- 125000002993 cycloalkylene group Chemical group 0.000 claims description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 230000001575 pathological effect Effects 0.000 claims description 3
- 210000004881 tumor cell Anatomy 0.000 claims description 3
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 claims description 2
- MGNLQALRHMQGRS-UHFFFAOYSA-N 3-[4-(1-methyl-4-phenylpyrrole-3-carbonyl)piperazin-1-yl]benzamide Chemical compound C=1C=CC=CC=1C1=CN(C)C=C1C(=O)N(CC1)CCN1C1=CC=CC(C(N)=O)=C1 MGNLQALRHMQGRS-UHFFFAOYSA-N 0.000 claims description 2
- FWCBBSTVUAASDV-UHFFFAOYSA-N 3-[4-(2-amino-4-phenyl-1,3-thiazole-5-carbonyl)piperazin-1-yl]benzamide Chemical compound NC(=O)C1=CC=CC(N2CCN(CC2)C(=O)C2=C(N=C(N)S2)C=2C=CC=CC=2)=C1 FWCBBSTVUAASDV-UHFFFAOYSA-N 0.000 claims description 2
- OSMVJIRBVRPVLQ-UHFFFAOYSA-N 3-[4-(3-phenyl-1h-pyrrole-2-carbonyl)piperazin-1-yl]benzamide Chemical compound NC(=O)C1=CC=CC(N2CCN(CC2)C(=O)C2=C(C=CN2)C=2C=CC=CC=2)=C1 OSMVJIRBVRPVLQ-UHFFFAOYSA-N 0.000 claims description 2
- AIWHFPNNPDGVST-UHFFFAOYSA-N 3-[4-(4-phenyl-1h-pyrrole-3-carbonyl)piperazin-1-yl]benzamide Chemical compound NC(=O)C1=CC=CC(N2CCN(CC2)C(=O)C=2C(=CNC=2)C=2C=CC=CC=2)=C1 AIWHFPNNPDGVST-UHFFFAOYSA-N 0.000 claims description 2
- PUUUQTODUUKDOB-UHFFFAOYSA-N 3-[4-[2-(2-methoxyethylamino)-4-phenyl-1,3-thiazole-5-carbonyl]piperazin-1-yl]benzonitrile Chemical compound S1C(NCCOC)=NC(C=2C=CC=CC=2)=C1C(=O)N(CC1)CCN1C1=CC=CC(C#N)=C1 PUUUQTODUUKDOB-UHFFFAOYSA-N 0.000 claims description 2
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims description 2
- SCXTYHPIUZWMRP-UHFFFAOYSA-N 5-[4-(3,5-dimethoxyphenyl)piperazine-1-carbonyl]-4-phenyl-3h-1,3-thiazol-2-one Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C2=C(N=C(O)S2)C=2C=CC=CC=2)=C1 SCXTYHPIUZWMRP-UHFFFAOYSA-N 0.000 claims description 2
- RFGDCADBISBUTA-UHFFFAOYSA-N [3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]-(4-pyridin-2-ylpiperazin-1-yl)methanone Chemical compound CC=1ON=C(C=2C(=CC=CC=2Cl)Cl)C=1C(=O)N(CC1)CCN1C1=CC=CC=N1 RFGDCADBISBUTA-UHFFFAOYSA-N 0.000 claims description 2
- QPTBXDYWAWRRBB-UHFFFAOYSA-N [3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]-[4-(2,3-dimethylphenyl)piperazin-1-yl]methanone Chemical compound CC=1ON=C(C=2C(=CC=CC=2Cl)Cl)C=1C(=O)N(CC1)CCN1C1=CC=CC(C)=C1C QPTBXDYWAWRRBB-UHFFFAOYSA-N 0.000 claims description 2
- YKLCDKIRJCRNOF-UHFFFAOYSA-N [3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]-[4-(2-fluorophenyl)piperazin-1-yl]methanone Chemical compound CC=1ON=C(C=2C(=CC=CC=2Cl)Cl)C=1C(=O)N(CC1)CCN1C1=CC=CC=C1F YKLCDKIRJCRNOF-UHFFFAOYSA-N 0.000 claims description 2
- NUZHFCHDSLXWMB-UHFFFAOYSA-N [3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]-[4-(4-fluorophenyl)piperazin-1-yl]methanone Chemical compound CC=1ON=C(C=2C(=CC=CC=2Cl)Cl)C=1C(=O)N(CC1)CCN1C1=CC=C(F)C=C1 NUZHFCHDSLXWMB-UHFFFAOYSA-N 0.000 claims description 2
- KFOWJXRKNNZZHQ-UHFFFAOYSA-N [3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methanone Chemical compound CC=1ON=C(C=2C(=CC=CC=2Cl)Cl)C=1C(=O)N(CC1)CCN1C1=CC=CC(C(F)(F)F)=C1 KFOWJXRKNNZZHQ-UHFFFAOYSA-N 0.000 claims description 2
- FQQQIDMUZUMOGS-UHFFFAOYSA-N [3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]-[4-(2-methoxyphenyl)piperazin-1-yl]methanone Chemical compound COC1=CC=CC=C1N1CCN(C(=O)C=2C(=NOC=2C)C=2C(=CC=CC=2F)Cl)CC1 FQQQIDMUZUMOGS-UHFFFAOYSA-N 0.000 claims description 2
- FIHFGMDCKYBDSH-UHFFFAOYSA-N [3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]-(4-pyridin-2-ylpiperazin-1-yl)methanone Chemical compound CC=1ON=C(C=2C(=CC=CC=2)Cl)C=1C(=O)N(CC1)CCN1C1=CC=CC=N1 FIHFGMDCKYBDSH-UHFFFAOYSA-N 0.000 claims description 2
- WVUKBGUNJPPZKT-UHFFFAOYSA-N [3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]-[4-(2-methoxyphenyl)piperazin-1-yl]methanone Chemical compound COC1=CC=CC=C1N1CCN(C(=O)C=2C(=NOC=2C)C=2C(=CC=CC=2)Cl)CC1 WVUKBGUNJPPZKT-UHFFFAOYSA-N 0.000 claims description 2
- VZPGZECGVVSLET-UHFFFAOYSA-N [3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]-[4-(3-chlorophenyl)piperazin-1-yl]methanone Chemical compound CC=1ON=C(C=2C(=CC=CC=2)Cl)C=1C(=O)N(CC1)CCN1C1=CC=CC(Cl)=C1 VZPGZECGVVSLET-UHFFFAOYSA-N 0.000 claims description 2
- JHUVHAANGXSBSY-UHFFFAOYSA-N [3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]-[4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]methanone Chemical compound CC=1ON=C(C=2C(=CC=CC=2)Cl)C=1C(=O)N(CC1)CCN1C1=NC=C(C(F)(F)F)C=C1Cl JHUVHAANGXSBSY-UHFFFAOYSA-N 0.000 claims description 2
- OWXBJAPOSQSWAO-UHFFFAOYSA-N [4-(2-chloro-4-nitrophenyl)piperazin-1-yl]-(5-methyl-3-phenyl-1,2-oxazol-4-yl)methanone Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1C(=O)N(CC1)CCN1C1=CC=C([N+]([O-])=O)C=C1Cl OWXBJAPOSQSWAO-UHFFFAOYSA-N 0.000 claims description 2
- HHZMWKNOCCEMIJ-UHFFFAOYSA-N [4-(2-chlorophenyl)-5-methyl-1,2-oxazol-3-yl]-[4-(2-fluorophenyl)piperazin-1-yl]methanone Chemical compound C=1C=CC=C(Cl)C=1C1=C(C)ON=C1C(=O)N(CC1)CCN1C1=CC=CC=C1F HHZMWKNOCCEMIJ-UHFFFAOYSA-N 0.000 claims description 2
- OHIQYDFDYIMGRD-UHFFFAOYSA-N [4-(2-chlorophenyl)-5-methyl-1,2-oxazol-3-yl]-[4-(4-fluorophenyl)piperazin-1-yl]methanone Chemical compound C=1C=CC=C(Cl)C=1C1=C(C)ON=C1C(=O)N(CC1)CCN1C1=CC=C(F)C=C1 OHIQYDFDYIMGRD-UHFFFAOYSA-N 0.000 claims description 2
- KDDUFNRXJZVCGN-UHFFFAOYSA-N [4-(2-fluorophenyl)piperazin-1-yl]-(4-phenylthiadiazol-5-yl)methanone Chemical compound FC1=CC=CC=C1N1CCN(C(=O)C2=C(N=NS2)C=2C=CC=CC=2)CC1 KDDUFNRXJZVCGN-UHFFFAOYSA-N 0.000 claims description 2
- GOEPFJGUMPLVOG-UHFFFAOYSA-N [4-(2-fluorophenyl)piperazin-1-yl]-(5-methyl-3-phenyl-1,2-oxazol-4-yl)methanone Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1C(=O)N(CC1)CCN1C1=CC=CC=C1F GOEPFJGUMPLVOG-UHFFFAOYSA-N 0.000 claims description 2
- DCIXECPRAXUAMO-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-(1-methyl-2-methylsulfanyl-5-phenylimidazol-4-yl)methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C2=C(N(C)C(SC)=N2)C=2C=CC=CC=2)=C1 DCIXECPRAXUAMO-UHFFFAOYSA-N 0.000 claims description 2
- ZLMTYHIPIODBGR-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-(1-methyl-2-phenylpyrrol-3-yl)methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C2=C(N(C)C=C2)C=2C=CC=CC=2)=C1 ZLMTYHIPIODBGR-UHFFFAOYSA-N 0.000 claims description 2
- ONNDHHBHLXCKTE-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-(2-methylsulfonyl-4-phenyl-1h-imidazol-5-yl)methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C2=C(N=C(N2)S(C)(=O)=O)C=2C=CC=CC=2)=C1 ONNDHHBHLXCKTE-UHFFFAOYSA-N 0.000 claims description 2
- RBJKVCUOOLRIJY-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-(4-phenyl-1,3-thiazol-5-yl)methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C2=C(N=CS2)C=2C=CC=CC=2)=C1 RBJKVCUOOLRIJY-UHFFFAOYSA-N 0.000 claims description 2
- UPPIQJMQCOKLFP-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-(4-phenyl-1h-imidazol-5-yl)methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C2=C(N=CN2)C=2C=CC=CC=2)=C1 UPPIQJMQCOKLFP-UHFFFAOYSA-N 0.000 claims description 2
- DWBWNWJNADJNBS-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-[1-(2-hydroxyethyl)-4-phenylpyrrol-3-yl]methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C=2C(=CN(CCO)C=2)C=2C=CC=CC=2)=C1 DWBWNWJNADJNBS-UHFFFAOYSA-N 0.000 claims description 2
- VFEOPGDDGZTXOA-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-[1-(hydroxymethyl)-4-phenylpyrrol-3-yl]methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C=2C(=CN(CO)C=2)C=2C=CC=CC=2)=C1 VFEOPGDDGZTXOA-UHFFFAOYSA-N 0.000 claims description 2
- YRFHMXBFNPQYAP-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-[2-(2-methoxyethylamino)-4-phenyl-1,3-thiazol-5-yl]methanone Chemical compound S1C(NCCOC)=NC(C=2C=CC=CC=2)=C1C(=O)N(CC1)CCN1C1=CC(OC)=CC(OC)=C1 YRFHMXBFNPQYAP-UHFFFAOYSA-N 0.000 claims description 2
- DQMKNHROPZQKGW-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-[4-phenyl-1-(pyridin-3-ylmethyl)pyrrol-3-yl]methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C=2C(=CN(CC=3C=NC=CC=3)C=2)C=2C=CC=CC=2)=C1 DQMKNHROPZQKGW-UHFFFAOYSA-N 0.000 claims description 2
- KSGKIURWMIQOQJ-UHFFFAOYSA-N [4-(3-chlorophenyl)piperazin-1-yl]-(4-phenyl-1h-imidazol-5-yl)methanone Chemical compound ClC1=CC=CC(N2CCN(CC2)C(=O)C2=C(N=CN2)C=2C=CC=CC=2)=C1 KSGKIURWMIQOQJ-UHFFFAOYSA-N 0.000 claims description 2
- VIMQHHSIPAKERJ-UHFFFAOYSA-N [4-(3-chlorophenyl)piperazin-1-yl]-(5-phenyl-1,3-oxazol-4-yl)methanone Chemical compound ClC1=CC=CC(N2CCN(CC2)C(=O)C2=C(OC=N2)C=2C=CC=CC=2)=C1 VIMQHHSIPAKERJ-UHFFFAOYSA-N 0.000 claims description 2
- DPKCHQOPFHKJPB-UHFFFAOYSA-N [4-(3-chlorophenyl)piperazin-1-yl]-[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]methanone Chemical compound CC=1ON=C(C=2C(=CC=CC=2Cl)Cl)C=1C(=O)N(CC1)CCN1C1=CC=CC(Cl)=C1 DPKCHQOPFHKJPB-UHFFFAOYSA-N 0.000 claims description 2
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 125000002946 cyanobenzyl group Chemical group 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 229940002612 prodrug Drugs 0.000 claims description 2
- 239000000651 prodrug Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 230000002792 vascular Effects 0.000 claims description 2
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 2
- BULYQULHSJTEFI-UHFFFAOYSA-N (2,5-dimethyl-4-phenylfuran-3-yl)-(4-pyridin-2-ylpiperazin-1-yl)methanone Chemical compound CC=1OC(C)=C(C=2C=CC=CC=2)C=1C(=O)N(CC1)CCN1C1=CC=CC=N1 BULYQULHSJTEFI-UHFFFAOYSA-N 0.000 claims 1
- BZNNBSRLVYNHAS-UHFFFAOYSA-N 2-[3-[4-(3,5-dimethoxyphenyl)piperazine-1-carbonyl]-4-phenylpyrrol-1-yl]acetic acid Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C=2C(=CN(CC(O)=O)C=2)C=2C=CC=CC=2)=C1 BZNNBSRLVYNHAS-UHFFFAOYSA-N 0.000 claims 1
- JKPTUXAJNUGFNI-UHFFFAOYSA-N 3-[3-[4-(3-chlorophenyl)piperazine-1-carbonyl]-4-phenylpyrrol-1-yl]propanoic acid Chemical compound C=1C=CC=CC=1C1=CN(CCC(=O)O)C=C1C(=O)N(CC1)CCN1C1=CC=CC(Cl)=C1 JKPTUXAJNUGFNI-UHFFFAOYSA-N 0.000 claims 1
- HXDKQFRUUMYXFI-UHFFFAOYSA-N 3-[4-(2-oxo-5-phenyl-1,3-dihydroimidazole-4-carbonyl)piperazin-1-yl]benzamide Chemical compound NC(=O)C1=CC=CC(N2CCN(CC2)C(=O)C2=C(N=C(O)N2)C=2C=CC=CC=2)=C1 HXDKQFRUUMYXFI-UHFFFAOYSA-N 0.000 claims 1
- JTIAFBAAEUDXGG-UHFFFAOYSA-N 3-[4-[2-(2-methoxyethylamino)-4-phenyl-1,3-thiazole-5-carbonyl]piperazin-1-yl]benzamide Chemical compound S1C(NCCOC)=NC(C=2C=CC=CC=2)=C1C(=O)N(CC1)CCN1C1=CC=CC(C(N)=O)=C1 JTIAFBAAEUDXGG-UHFFFAOYSA-N 0.000 claims 1
- 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 claims 1
- XOULNWKRRGEGHW-UHFFFAOYSA-N 4-[4-(3,5-dimethoxyphenyl)piperazine-1-carbonyl]-5-phenyl-1,3-dihydroimidazol-2-one Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C2=C(NC(O)=N2)C=2C=CC=CC=2)=C1 XOULNWKRRGEGHW-UHFFFAOYSA-N 0.000 claims 1
- BNWDQWYSAQEDHZ-UHFFFAOYSA-N 4-[4-[3-(hydroxymethyl)phenyl]piperazine-1-carbonyl]-5-phenyl-1,3-dihydroimidazol-2-one Chemical compound OCC1=CC=CC(N2CCN(CC2)C(=O)C2=C(N=C(O)N2)C=2C=CC=CC=2)=C1 BNWDQWYSAQEDHZ-UHFFFAOYSA-N 0.000 claims 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 1
- XZRAZBBODBSFKM-UHFFFAOYSA-N [1-(1-hydroxyethyl)-5-phenylpyrrol-2-yl]-[4-[3-(hydroxymethyl)phenyl]piperazin-1-yl]methanone Chemical compound CC(O)N1C(C(=O)N2CCN(CC2)C=2C=C(CO)C=CC=2)=CC=C1C1=CC=CC=C1 XZRAZBBODBSFKM-UHFFFAOYSA-N 0.000 claims 1
- IMBCURQZYXRXET-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-(2-methylsulfanyl-4-phenyl-1h-imidazol-5-yl)methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C2=C(NC(SC)=N2)C=2C=CC=CC=2)=C1 IMBCURQZYXRXET-UHFFFAOYSA-N 0.000 claims 1
- YHNLLCBHNKFMHP-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-(2-methylsulfinyl-4-phenyl-1h-imidazol-5-yl)methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C2=C(NC(=N2)S(C)=O)C=2C=CC=CC=2)=C1 YHNLLCBHNKFMHP-UHFFFAOYSA-N 0.000 claims 1
- GFHYHAMWWWMKJT-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-(5-methyl-3-phenyl-1,2-oxazol-4-yl)methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C=2C(=NOC=2C)C=2C=CC=CC=2)=C1 GFHYHAMWWWMKJT-UHFFFAOYSA-N 0.000 claims 1
- XCKUDSAUYUJIDS-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-[4-phenyl-2-(trifluoromethyl)-1h-imidazol-5-yl]methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C2=C(N=C(N2)C(F)(F)F)C=2C=CC=CC=2)=C1 XCKUDSAUYUJIDS-UHFFFAOYSA-N 0.000 claims 1
- IYPYJVAROLJHPB-UHFFFAOYSA-N [4-(3-chlorophenyl)piperazin-1-yl]-(1-phenylimidazol-2-yl)methanone Chemical compound ClC1=CC=CC(N2CCN(CC2)C(=O)C=2N(C=CN=2)C=2C=CC=CC=2)=C1 IYPYJVAROLJHPB-UHFFFAOYSA-N 0.000 claims 1
- PGBCNRJBTPSOKW-UHFFFAOYSA-N [4-(3-methoxyphenyl)piperazin-1-yl]-(2-phenylpyrazol-3-yl)methanone Chemical compound COC1=CC=CC(N2CCN(CC2)C(=O)C=2N(N=CC=2)C=2C=CC=CC=2)=C1 PGBCNRJBTPSOKW-UHFFFAOYSA-N 0.000 claims 1
- MJIAEQNZNAPBNG-UHFFFAOYSA-N [4-(4-amino-3-nitrophenyl)-2,5-dimethylfuran-3-yl]-(4-phenylpiperazin-1-yl)methanone Chemical compound CC=1OC(C)=C(C=2C=C(C(N)=CC=2)[N+]([O-])=O)C=1C(=O)N(CC1)CCN1C1=CC=CC=C1 MJIAEQNZNAPBNG-UHFFFAOYSA-N 0.000 claims 1
- WKPLMFYVYLQMPS-UHFFFAOYSA-N [4-(6-methylpyridin-2-yl)piperazin-1-yl]-(2-phenylpyrazol-3-yl)methanone Chemical compound CC1=CC=CC(N2CCN(CC2)C(=O)C=2N(N=CC=2)C=2C=CC=CC=2)=N1 WKPLMFYVYLQMPS-UHFFFAOYSA-N 0.000 claims 1
- IPPYKVVIHANXTQ-UHFFFAOYSA-N [4-[3-(hydroxymethyl)phenyl]piperazin-1-yl]-[4-phenyl-2-(trifluoromethyl)-1h-imidazol-5-yl]methanone Chemical compound OCC1=CC=CC(N2CCN(CC2)C(=O)C2=C(N=C(N2)C(F)(F)F)C=2C=CC=CC=2)=C1 IPPYKVVIHANXTQ-UHFFFAOYSA-N 0.000 claims 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims 1
- 150000002460 imidazoles Chemical class 0.000 claims 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000000168 pyrrolyl group Chemical group 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 519
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 225
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 192
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 132
- 238000001819 mass spectrum Methods 0.000 description 110
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 108
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 102
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 100
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 94
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 90
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 87
- 230000002829 reductive effect Effects 0.000 description 87
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 80
- 238000003818 flash chromatography Methods 0.000 description 76
- 239000000741 silica gel Substances 0.000 description 76
- 229910002027 silica gel Inorganic materials 0.000 description 76
- 238000003756 stirring Methods 0.000 description 74
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 69
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 69
- 238000000746 purification Methods 0.000 description 69
- 239000007787 solid Substances 0.000 description 68
- 238000000034 method Methods 0.000 description 67
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 65
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 57
- 239000000243 solution Substances 0.000 description 55
- 239000000047 product Substances 0.000 description 45
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 43
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 42
- JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 40
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 39
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 37
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 36
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 34
- 235000019341 magnesium sulphate Nutrition 0.000 description 34
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 31
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 30
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 30
- 239000003921 oil Substances 0.000 description 27
- 235000019198 oils Nutrition 0.000 description 27
- 238000002425 crystallisation Methods 0.000 description 24
- 238000010908 decantation Methods 0.000 description 24
- 239000011541 reaction mixture Substances 0.000 description 22
- 238000001816 cooling Methods 0.000 description 21
- 230000008018 melting Effects 0.000 description 21
- 238000002844 melting Methods 0.000 description 21
- 230000008025 crystallization Effects 0.000 description 20
- 239000013078 crystal Substances 0.000 description 19
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 18
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 17
- 239000012074 organic phase Substances 0.000 description 17
- 239000007864 aqueous solution Substances 0.000 description 16
- 239000000377 silicon dioxide Substances 0.000 description 16
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 15
- 239000002244 precipitate Substances 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000003480 eluent Substances 0.000 description 14
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 14
- 239000011734 sodium Substances 0.000 description 14
- 238000001953 recrystallisation Methods 0.000 description 13
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 12
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 12
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 12
- 239000002585 base Substances 0.000 description 12
- 150000004678 hydrides Chemical class 0.000 description 12
- 229910052708 sodium Inorganic materials 0.000 description 12
- 239000012312 sodium hydride Substances 0.000 description 12
- 229910000104 sodium hydride Inorganic materials 0.000 description 12
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 11
- 239000000284 extract Substances 0.000 description 11
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 11
- 238000010992 reflux Methods 0.000 description 11
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 10
- 238000001035 drying Methods 0.000 description 10
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 238000004587 chromatography analysis Methods 0.000 description 9
- 239000003643 water by type Substances 0.000 description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 8
- COWMQOCYJSUFSB-UHFFFAOYSA-N 1-(3,5-dimethoxyphenyl)piperazine Chemical compound COC1=CC(OC)=CC(N2CCNCC2)=C1 COWMQOCYJSUFSB-UHFFFAOYSA-N 0.000 description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 7
- 239000008346 aqueous phase Substances 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 150000004885 piperazines Chemical class 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- VHFVKMTVMIZMIK-UHFFFAOYSA-N 1-(3-chlorophenyl)piperazine Chemical compound ClC1=CC=CC(N2CCNCC2)=C1 VHFVKMTVMIZMIK-UHFFFAOYSA-N 0.000 description 6
- JBKINHFZTVLNEM-UHFFFAOYSA-N 2-bromoethoxy-tert-butyl-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)OCCBr JBKINHFZTVLNEM-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 6
- 239000012429 reaction media Substances 0.000 description 6
- 238000010898 silica gel chromatography Methods 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- VNKAOZFTIGAIPR-UHFFFAOYSA-N 2-amino-4-phenyl-1,3-thiazole-5-carboxylic acid Chemical compound S1C(N)=NC(C=2C=CC=CC=2)=C1C(O)=O VNKAOZFTIGAIPR-UHFFFAOYSA-N 0.000 description 5
- VICOSPWZPSCMHY-UHFFFAOYSA-N 2-methyl-4-phenyl-1h-imidazole-5-carboxylic acid Chemical compound N1C(C)=NC(C=2C=CC=CC=2)=C1C(O)=O VICOSPWZPSCMHY-UHFFFAOYSA-N 0.000 description 5
- IIQFBTDWCPUWJG-UHFFFAOYSA-N 2-methylsulfonyl-4-phenyl-1h-imidazole-5-carboxylic acid Chemical compound N1C(S(=O)(=O)C)=NC(C=2C=CC=CC=2)=C1C(O)=O IIQFBTDWCPUWJG-UHFFFAOYSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 5
- UICZVYGCGBFRTO-UHFFFAOYSA-N amino 2-(2-methoxyethyl)-4-phenyl-1,3-thiazole-5-carboxylate Chemical compound COCCC=1SC(=C(N=1)C1=CC=CC=C1)C(=O)ON UICZVYGCGBFRTO-UHFFFAOYSA-N 0.000 description 5
- 229910052786 argon Inorganic materials 0.000 description 5
- 244000309464 bull Species 0.000 description 5
- 125000005805 dimethoxy phenyl group Chemical group 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- RDPLOLUNEKBWBR-UHFFFAOYSA-L magnesium;sodium;sulfate Chemical compound [Na+].[Mg+2].[O-]S([O-])(=O)=O RDPLOLUNEKBWBR-UHFFFAOYSA-L 0.000 description 5
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 4
- LJUHEEFEADORHV-UHFFFAOYSA-N 3-piperazin-1-ylbenzonitrile Chemical compound N#CC1=CC=CC(N2CCNCC2)=C1 LJUHEEFEADORHV-UHFFFAOYSA-N 0.000 description 4
- UCDOBYGHVUULRO-UHFFFAOYSA-N 3-piperazin-1-ylbenzonitrile;dihydrochloride Chemical compound Cl.Cl.N#CC1=CC=CC(N2CCNCC2)=C1 UCDOBYGHVUULRO-UHFFFAOYSA-N 0.000 description 4
- VZTQYHRMGFZHQD-UHFFFAOYSA-N 5-phenyl-2-sulfanylidene-1,3-dihydroimidazole-4-carboxylic acid Chemical compound N1C(S)=NC(C=2C=CC=CC=2)=C1C(=O)O VZTQYHRMGFZHQD-UHFFFAOYSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical group C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 4
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 4
- GQTJEWBTNLPAFU-UHFFFAOYSA-N (3-piperazin-1-ylphenyl)methanol;dihydrochloride Chemical compound Cl.Cl.OCC1=CC=CC(N2CCNCC2)=C1 GQTJEWBTNLPAFU-UHFFFAOYSA-N 0.000 description 3
- 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 3
- JKPQOHQTACWXPF-UHFFFAOYSA-N 3-phenyl-1h-pyrrole-2-carboxylic acid Chemical compound N1C=CC(C=2C=CC=CC=2)=C1C(=O)O JKPQOHQTACWXPF-UHFFFAOYSA-N 0.000 description 3
- FHNJGCZCAODEEQ-UHFFFAOYSA-N 3-piperazin-1-ylphenol;dihydrochloride Chemical compound Cl.Cl.OC1=CC=CC(N2CCNCC2)=C1 FHNJGCZCAODEEQ-UHFFFAOYSA-N 0.000 description 3
- XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- 235000019502 Orange oil Nutrition 0.000 description 3
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- CVVIJWRCGSYCMB-UHFFFAOYSA-N hydron;piperazine;dichloride Chemical compound Cl.Cl.C1CNCCN1 CVVIJWRCGSYCMB-UHFFFAOYSA-N 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 150000002545 isoxazoles Chemical class 0.000 description 3
- 239000010502 orange oil Substances 0.000 description 3
- IENZQIKPVFGBNW-UHFFFAOYSA-N prazosin Chemical class N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 IENZQIKPVFGBNW-UHFFFAOYSA-N 0.000 description 3
- XKMLYUALXHKNFT-UHFFFAOYSA-N rGTP Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O XKMLYUALXHKNFT-UHFFFAOYSA-N 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 238000007280 thionation reaction Methods 0.000 description 3
- 150000008083 1,2,3,6-tetrahydropyridines Chemical class 0.000 description 2
- PZIBVWUXWNYTNL-UHFFFAOYSA-N 1-(3-methoxyphenyl)piperazine Chemical compound COC1=CC=CC(N2CCNCC2)=C1 PZIBVWUXWNYTNL-UHFFFAOYSA-N 0.000 description 2
- AIDJMQKZDVULAF-UHFFFAOYSA-N 1-[3-[4-(3,5-dimethoxyphenyl)piperazine-1-carbonyl]-2-phenylpyrrol-1-yl]ethanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C2=C(N(C(C)=O)C=C2)C=2C=CC=CC=2)=C1 AIDJMQKZDVULAF-UHFFFAOYSA-N 0.000 description 2
- MQLACMBJVPINKE-UHFFFAOYSA-N 10-[(3-hydroxy-4-methoxyphenyl)methylidene]anthracen-9-one Chemical compound C1=C(O)C(OC)=CC=C1C=C1C2=CC=CC=C2C(=O)C2=CC=CC=C21 MQLACMBJVPINKE-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- APXSARIYDLVPAY-UHFFFAOYSA-N 2-methyl-4-phenyl-1,3-thiazole-5-carboxylic acid Chemical compound S1C(C)=NC(C=2C=CC=CC=2)=C1C(O)=O APXSARIYDLVPAY-UHFFFAOYSA-N 0.000 description 2
- JCTHYQGCFVQWNK-UHFFFAOYSA-N 2-methylsulfanyl-4-phenyl-1H-imidazole-5-carboxylic acid Chemical compound N1C(SC)=NC(C=2C=CC=CC=2)=C1C(O)=O JCTHYQGCFVQWNK-UHFFFAOYSA-N 0.000 description 2
- FWXHDKIZGOTPPF-UHFFFAOYSA-N 2-oxo-4-phenyl-3h-1,3-thiazole-5-carboxylic acid Chemical compound S1C(O)=NC(C=2C=CC=CC=2)=C1C(=O)O FWXHDKIZGOTPPF-UHFFFAOYSA-N 0.000 description 2
- OEUUDKWBUGDTGL-UHFFFAOYSA-N 2-phenyl-1h-pyrrole-3-carboxylic acid Chemical compound C1=CNC(C=2C=CC=CC=2)=C1C(=O)O OEUUDKWBUGDTGL-UHFFFAOYSA-N 0.000 description 2
- KHCXGFNZZRXOND-UHFFFAOYSA-N 3-(bromomethyl)pyridine Chemical compound BrCC1=CC=CN=C1 KHCXGFNZZRXOND-UHFFFAOYSA-N 0.000 description 2
- FNHPUOJKUXFUKN-UHFFFAOYSA-N 3-(bromomethyl)pyridine;hydron;bromide Chemical compound Br.BrCC1=CC=CN=C1 FNHPUOJKUXFUKN-UHFFFAOYSA-N 0.000 description 2
- GALSDOHLAKFIBA-UHFFFAOYSA-N 3-[4-(2-methylsulfanyl-4-phenyl-1h-imidazole-5-carbonyl)piperazin-1-yl]benzonitrile Chemical compound N1C(SC)=NC(C=2C=CC=CC=2)=C1C(=O)N(CC1)CCN1C1=CC=CC(C#N)=C1 GALSDOHLAKFIBA-UHFFFAOYSA-N 0.000 description 2
- LUSHKMRYBKWJGE-UHFFFAOYSA-N 3-[4-(2-oxo-5-phenyl-1,3-dihydroimidazole-4-carbonyl)piperazin-1-yl]benzonitrile Chemical compound N1C(O)=NC(C=2C=CC=CC=2)=C1C(=O)N(CC1)CCN1C1=CC=CC(C#N)=C1 LUSHKMRYBKWJGE-UHFFFAOYSA-N 0.000 description 2
- QSBGOQPVAJOLDM-UHFFFAOYSA-N 3-[4-[1-(1-hydroxyethyl)-2-phenylpyrrole-3-carbonyl]piperazin-1-yl]benzamide Chemical compound C=1C=CC=CC=1C=1N(C(O)C)C=CC=1C(=O)N(CC1)CCN1C1=CC=CC(C(N)=O)=C1 QSBGOQPVAJOLDM-UHFFFAOYSA-N 0.000 description 2
- NOJPHWCXWAYZFS-UHFFFAOYSA-N 3-piperazin-1-ylbenzamide Chemical compound NC(=O)C1=CC=CC(N2CCNCC2)=C1 NOJPHWCXWAYZFS-UHFFFAOYSA-N 0.000 description 2
- NGTZFWMOTDGMKO-UHFFFAOYSA-N 4-phenyl-1,3-thiazole-5-carboxylic acid Chemical compound S1C=NC(C=2C=CC=CC=2)=C1C(=O)O NGTZFWMOTDGMKO-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 108091077621 MAPRE family Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 102000009664 Microtubule-Associated Proteins Human genes 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- HOULBRYZTMTERN-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-[2-phenyl-1-(pyridin-3-ylmethyl)pyrrol-3-yl]methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C2=C(N(CC=3C=NC=CC=3)C=C2)C=2C=CC=CC=2)=C1 HOULBRYZTMTERN-UHFFFAOYSA-N 0.000 description 2
- BRIZJOCBJNSECZ-UHFFFAOYSA-N [4-(3,5-dimethoxyphenyl)piperazin-1-yl]-[4-phenyl-1-(1,3-thiazol-4-ylmethyl)pyrrol-3-yl]methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C=2C(=CN(CC=3N=CSC=3)C=2)C=2C=CC=CC=2)=C1 BRIZJOCBJNSECZ-UHFFFAOYSA-N 0.000 description 2
- GYDZOYOOITWUFO-UHFFFAOYSA-N [4-(3-chlorophenyl)piperazin-1-yl]-(5-phenyl-2-sulfanylidene-1,3-dihydroimidazol-4-yl)methanone Chemical compound C=1C=CC=CC=1C=1NC(S)=NC=1C(=O)N(CC1)CCN1C1=CC=CC(Cl)=C1 GYDZOYOOITWUFO-UHFFFAOYSA-N 0.000 description 2
- WQCNPOUJOFYEEP-UHFFFAOYSA-N [4-[3-(difluoromethoxy)phenyl]piperazin-1-yl]-(4-phenyl-1h-imidazol-5-yl)methanone Chemical compound FC(F)OC1=CC=CC(N2CCN(CC2)C(=O)C2=C(NC=N2)C=2C=CC=CC=2)=C1 WQCNPOUJOFYEEP-UHFFFAOYSA-N 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 125000004802 cyanophenyl group Chemical group 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000004922 lacquer Substances 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- IVDFJHOHABJVEH-UHFFFAOYSA-N pinacol Chemical compound CC(C)(O)C(C)(C)O IVDFJHOHABJVEH-UHFFFAOYSA-N 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 2
- 125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 description 2
- 229940104230 thymidine Drugs 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- QSLPNSWXUQHVLP-UHFFFAOYSA-N $l^{1}-sulfanylmethane Chemical compound [S]C QSLPNSWXUQHVLP-UHFFFAOYSA-N 0.000 description 1
- CDBOBDXTCRCJJA-UHFFFAOYSA-N (2-amino-4-phenyl-1,3-thiazol-5-yl)-[4-(3,5-dimethoxyphenyl)piperazin-1-yl]methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C2=C(N=C(N)S2)C=2C=CC=CC=2)=C1 CDBOBDXTCRCJJA-UHFFFAOYSA-N 0.000 description 1
- RBSSPJDOINFUCR-UHFFFAOYSA-N 1-(3,5-dimethylphenyl)piperazine Chemical compound CC1=CC(C)=CC(N2CCNCC2)=C1 RBSSPJDOINFUCR-UHFFFAOYSA-N 0.000 description 1
- WEZRSRLKOVMNRG-UHFFFAOYSA-N 1-[3-(difluoromethoxy)phenyl]piperazine;dihydrochloride Chemical compound Cl.Cl.FC(F)OC1=CC=CC(N2CCNCC2)=C1 WEZRSRLKOVMNRG-UHFFFAOYSA-N 0.000 description 1
- QIIFRFPHEWZBAQ-UHFFFAOYSA-N 1-[3-(difluoromethoxy)phenyl]piperazine;hydrochloride Chemical compound Cl.FC(F)OC1=CC=CC(N2CCNCC2)=C1 QIIFRFPHEWZBAQ-UHFFFAOYSA-N 0.000 description 1
- XFIVHJKOEPNRCT-UHFFFAOYSA-N 1-[3-[4-(3,5-dimethoxyphenyl)piperazine-1-carbonyl]-4-phenylpyrrol-1-yl]ethanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C=2C(=CN(C=2)C(C)=O)C=2C=CC=CC=2)=C1 XFIVHJKOEPNRCT-UHFFFAOYSA-N 0.000 description 1
- KPTMLRRGBKWXAB-UHFFFAOYSA-N 1-methyl-2-phenylpyrrole-3-carboxylic acid Chemical compound CN1C=CC(C(O)=O)=C1C1=CC=CC=C1 KPTMLRRGBKWXAB-UHFFFAOYSA-N 0.000 description 1
- DNDJHEWLYGJJCY-UHFFFAOYSA-N 1-pyridin-3-ylpiperazine Chemical compound C1CNCCN1C1=CC=CN=C1 DNDJHEWLYGJJCY-UHFFFAOYSA-N 0.000 description 1
- FJFVSKLYCLSKPN-UHFFFAOYSA-N 2-(3-piperazin-1-ylphenyl)acetonitrile;dihydrochloride Chemical compound Cl.Cl.N#CCC1=CC=CC(N2CCNCC2)=C1 FJFVSKLYCLSKPN-UHFFFAOYSA-N 0.000 description 1
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 1
- DOZKJWRWSOBWIS-UHFFFAOYSA-N 2-[4-[1-[1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-phenylpyrrole-3-carbonyl]piperazin-1-yl]benzonitrile Chemical compound C(C)(C)(C)[Si](OC(C)N1C=C(C(=C1)C1=CC=CC=C1)C(=O)N1CCN(CC1)C1=C(C#N)C=CC=C1)(C)C DOZKJWRWSOBWIS-UHFFFAOYSA-N 0.000 description 1
- 125000006016 2-bromoethoxy group Chemical group 0.000 description 1
- ULQQGOGMQRGFFR-UHFFFAOYSA-N 2-chlorobenzenecarboperoxoic acid Chemical compound OOC(=O)C1=CC=CC=C1Cl ULQQGOGMQRGFFR-UHFFFAOYSA-N 0.000 description 1
- LQLJZSJKRYTKTP-UHFFFAOYSA-N 2-dimethylaminoethyl chloride hydrochloride Chemical compound Cl.CN(C)CCCl LQLJZSJKRYTKTP-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- BMIBJCFFZPYJHF-UHFFFAOYSA-N 2-methoxy-5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Chemical compound COC1=NC=C(C)C=C1B1OC(C)(C)C(C)(C)O1 BMIBJCFFZPYJHF-UHFFFAOYSA-N 0.000 description 1
- WIVXJYKYHMLEEO-UHFFFAOYSA-N 2-oxo-5-phenyl-1,3-dihydroimidazole-4-carboxylic acid Chemical compound N1C(=O)NC(C=2C=CC=CC=2)=C1C(=O)O WIVXJYKYHMLEEO-UHFFFAOYSA-N 0.000 description 1
- IRTLROCMFSDSNF-UHFFFAOYSA-N 2-phenyl-1h-pyrrole Chemical compound C1=CNC(C=2C=CC=CC=2)=C1 IRTLROCMFSDSNF-UHFFFAOYSA-N 0.000 description 1
- HQQHXNRWOJWVHF-UHFFFAOYSA-N 3-(4-chlorophenyl)furan-2-carboxylic acid Chemical compound O1C=CC(C=2C=CC(Cl)=CC=2)=C1C(=O)O HQQHXNRWOJWVHF-UHFFFAOYSA-N 0.000 description 1
- NDQQGQAFMKEMSD-UHFFFAOYSA-N 3-(bromomethyl)pyridin-1-ium;chloride Chemical compound Cl.BrCC1=CC=CN=C1 NDQQGQAFMKEMSD-UHFFFAOYSA-N 0.000 description 1
- DRLKOALDPMGLJV-UHFFFAOYSA-N 3-[4-(1-methyl-2-phenylpyrrole-3-carbonyl)piperazin-1-yl]benzamide Chemical compound C=1C=CC=CC=1C=1N(C)C=CC=1C(=O)N(CC1)CCN1C1=CC=CC(C(N)=O)=C1 DRLKOALDPMGLJV-UHFFFAOYSA-N 0.000 description 1
- ZNHCXYGJSDERCQ-UHFFFAOYSA-N 3-[4-(2-amino-4-phenyl-1,3-thiazole-5-carbonyl)piperazin-1-yl]benzonitrile Chemical compound S1C(N)=NC(C=2C=CC=CC=2)=C1C(=O)N(CC1)CCN1C1=CC=CC(C#N)=C1 ZNHCXYGJSDERCQ-UHFFFAOYSA-N 0.000 description 1
- CTHNOHWYNHLGMV-UHFFFAOYSA-N 3-[4-(2-methyl-4-phenyl-1h-imidazole-5-carbonyl)piperazin-1-yl]benzonitrile Chemical compound C=1C=CC=CC=1C=1NC(C)=NC=1C(=O)N(CC1)CCN1C1=CC=CC(C#N)=C1 CTHNOHWYNHLGMV-UHFFFAOYSA-N 0.000 description 1
- ANVWTMJBEHMJDK-UHFFFAOYSA-N 3-[4-(2-methylsulfanyl-4-phenyl-1h-imidazole-5-carbonyl)piperazin-1-yl]benzamide Chemical compound N1C(SC)=NC(C=2C=CC=CC=2)=C1C(=O)N(CC1)CCN1C1=CC=CC(C(N)=O)=C1 ANVWTMJBEHMJDK-UHFFFAOYSA-N 0.000 description 1
- NEHPYIZYRXFJNI-UHFFFAOYSA-N 3-[4-(2-methylsulfonyl-5-phenyl-1,4-dihydroimidazole-5-carbonyl)piperazin-1-yl]benzonitrile Chemical compound C1NC(S(=O)(=O)C)=NC1(C=1C=CC=CC=1)C(=O)N1CCN(C=2C=C(C=CC=2)C#N)CC1 NEHPYIZYRXFJNI-UHFFFAOYSA-N 0.000 description 1
- RYUWWELMYPXZKJ-UHFFFAOYSA-N 3-[4-(2-phenyl-1h-pyrrole-3-carbonyl)piperazin-1-yl]benzonitrile Chemical compound C1=CNC(C=2C=CC=CC=2)=C1C(=O)N(CC1)CCN1C1=CC=CC(C#N)=C1 RYUWWELMYPXZKJ-UHFFFAOYSA-N 0.000 description 1
- CTNPDNGKELIMSR-UHFFFAOYSA-N 3-[4-(3-phenyl-1h-pyrrole-2-carbonyl)piperazin-1-yl]benzonitrile Chemical compound N1C=CC(C=2C=CC=CC=2)=C1C(=O)N(CC1)CCN1C1=CC=CC(C#N)=C1 CTNPDNGKELIMSR-UHFFFAOYSA-N 0.000 description 1
- CHXKZVOYQIWWLU-UHFFFAOYSA-N 3-[4-[1-(1-hydroxyethyl)-2-phenylpyrrole-3-carbonyl]piperazin-1-yl]benzonitrile Chemical compound C=1C=CC=CC=1C=1N(C(O)C)C=CC=1C(=O)N(CC1)CCN1C1=CC=CC(C#N)=C1 CHXKZVOYQIWWLU-UHFFFAOYSA-N 0.000 description 1
- CIQKUWDCOUCJRU-UHFFFAOYSA-N 3-[4-[1-(1-hydroxyethyl)-4-phenylpyrrole-3-carbonyl]piperazin-1-yl]benzamide Chemical compound C=1C=CC=CC=1C1=CN(C(O)C)C=C1C(=O)N(CC1)CCN1C1=CC=CC(C(N)=O)=C1 CIQKUWDCOUCJRU-UHFFFAOYSA-N 0.000 description 1
- STZQWSSMWQRLDC-UHFFFAOYSA-N 3-[4-[1-(1-hydroxyethyl)-4-phenylpyrrole-3-carbonyl]piperazin-1-yl]benzonitrile Chemical compound C=1C=CC=CC=1C1=CN(C(O)C)C=C1C(=O)N(CC1)CCN1C1=CC=CC(C#N)=C1 STZQWSSMWQRLDC-UHFFFAOYSA-N 0.000 description 1
- CPBQHWOZKOBKHX-UHFFFAOYSA-N 3-[4-[1-(hydroxymethyl)-4-phenylpyrrole-3-carbonyl]piperazin-1-yl]benzonitrile Chemical compound C=1C=CC=CC=1C1=CN(CO)C=C1C(=O)N(CC1)CCN1C1=CC=CC(C#N)=C1 CPBQHWOZKOBKHX-UHFFFAOYSA-N 0.000 description 1
- KNFJXXWJPOVNAZ-UHFFFAOYSA-N 3-[4-[4-phenyl-2-(trifluoromethyl)-1h-imidazole-5-carbonyl]piperazin-1-yl]benzamide Chemical compound NC(=O)C1=CC=CC(N2CCN(CC2)C(=O)C2=C(N=C(N2)C(F)(F)F)C=2C=CC=CC=2)=C1 KNFJXXWJPOVNAZ-UHFFFAOYSA-N 0.000 description 1
- COVMDYQQYPZRGL-UHFFFAOYSA-N 3-[4-[4-phenyl-2-(trifluoromethyl)-1h-imidazole-5-carbonyl]piperazin-1-yl]benzonitrile Chemical compound N1C(C(F)(F)F)=NC(C=2C=CC=CC=2)=C1C(=O)N(CC1)CCN1C1=CC=CC(C#N)=C1 COVMDYQQYPZRGL-UHFFFAOYSA-N 0.000 description 1
- STXAVEHFKAXGOX-UHFFFAOYSA-N 3-bromobenzonitrile Chemical compound BrC1=CC=CC(C#N)=C1 STXAVEHFKAXGOX-UHFFFAOYSA-N 0.000 description 1
- KWWGBNRBZMJKPA-UHFFFAOYSA-N 3-phenylthiophene-2-carboxylic acid Chemical compound S1C=CC(C=2C=CC=CC=2)=C1C(=O)O KWWGBNRBZMJKPA-UHFFFAOYSA-N 0.000 description 1
- HUUNJDIASCEFMX-UHFFFAOYSA-N 3-piperazin-1-ylbenzamide;dihydrochloride Chemical compound Cl.Cl.NC(=O)C1=CC=CC(N2CCNCC2)=C1 HUUNJDIASCEFMX-UHFFFAOYSA-N 0.000 description 1
- NVTBASMQHFMANH-UHFFFAOYSA-N 4-(chloromethyl)-1,3-thiazole;hydron;chloride Chemical compound Cl.ClCC1=CSC=N1 NVTBASMQHFMANH-UHFFFAOYSA-N 0.000 description 1
- YNOAMDJRZSNZPH-UHFFFAOYSA-N 4-[3-[4-(3,5-dimethoxyphenyl)piperazine-1-carbonyl]-4-phenylpyrrol-1-yl]butanoic acid Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C=2C(=CN(CCCC(O)=O)C=2)C=2C=CC=CC=2)=C1 YNOAMDJRZSNZPH-UHFFFAOYSA-N 0.000 description 1
- JUCLXFPLJNDBJO-UHFFFAOYSA-N 4-phenyl-1,3-dihydroimidazol-2-one Chemical compound N1C(=O)NC=C1C1=CC=CC=C1 JUCLXFPLJNDBJO-UHFFFAOYSA-N 0.000 description 1
- UXIWLHNMLDJWMF-UHFFFAOYSA-N 4-phenyl-3h-1,3-thiazol-2-one Chemical compound S1C(O)=NC(C=2C=CC=CC=2)=C1 UXIWLHNMLDJWMF-UHFFFAOYSA-N 0.000 description 1
- VRJHQPZVIGNGMX-UHFFFAOYSA-N 4-piperidinone Chemical class O=C1CCNCC1 VRJHQPZVIGNGMX-UHFFFAOYSA-N 0.000 description 1
- RUKDIKJSGDVSIF-UHFFFAOYSA-N 5-phenyl-1,3-oxazole-4-carboxylic acid Chemical compound N1=COC(C=2C=CC=CC=2)=C1C(=O)O RUKDIKJSGDVSIF-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- YKLSIVBOWHBLQF-UHFFFAOYSA-N COC=1C=C(C=C(C1)OC)N1CCN(CC1)Cl Chemical compound COC=1C=C(C=C(C1)OC)N1CCN(CC1)Cl YKLSIVBOWHBLQF-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- 102000005454 Dimethylallyltranstransferase Human genes 0.000 description 1
- 108010006731 Dimethylallyltranstransferase Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 229940123583 Factor Xa inhibitor Drugs 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 1
- APUXHTNTNMAMNE-UHFFFAOYSA-N [1-[1-[tert-butyl(dimethyl)silyl]oxyethyl]-5-phenylpyrrol-2-yl]-[4-[3-(hydroxymethyl)phenyl]piperazin-1-yl]methanone Chemical compound CC(C)(C)[Si](C)(C)OC(C)N1C(C(=O)N2CCN(CC2)C=2C=C(CO)C=CC=2)=CC=C1C1=CC=CC=C1 APUXHTNTNMAMNE-UHFFFAOYSA-N 0.000 description 1
- FXECOFBSHWFXSB-UHFFFAOYSA-N [1-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-4-phenylpyrrol-3-yl]-[4-(3,5-dimethoxyphenyl)piperazin-1-yl]methanone Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C(=O)C=2C(=CN(CCO[Si](C)(C)C(C)(C)C)C=2)C=2C=CC=CC=2)=C1 FXECOFBSHWFXSB-UHFFFAOYSA-N 0.000 description 1
- QQKQEAWOHYCALI-UHFFFAOYSA-N [4-(2-hydroxy-3,5-dimethoxyphenyl)piperazin-1-yl]-(2-methylsulfinyl-4-phenyl-1h-imidazol-5-yl)methanone Chemical compound COC1=CC(OC)=C(O)C(N2CCN(CC2)C(=O)C2=C(NC(=N2)S(C)=O)C=2C=CC=CC=2)=C1 QQKQEAWOHYCALI-UHFFFAOYSA-N 0.000 description 1
- OPHMQDYMDVBYNH-UHFFFAOYSA-N [4-(3-chlorophenyl)piperazin-1-yl]-(3-phenylimidazol-4-yl)methanone Chemical compound ClC1=CC=CC(N2CCN(CC2)C(=O)C=2N(C=NC=2)C=2C=CC=CC=2)=C1 OPHMQDYMDVBYNH-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 238000006254 arylation reaction Methods 0.000 description 1
- 229940090047 auto-injector Drugs 0.000 description 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- KDPAWGWELVVRCH-UHFFFAOYSA-M bromoacetate Chemical compound [O-]C(=O)CBr KDPAWGWELVVRCH-UHFFFAOYSA-M 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- JZBWUTVDIDNCMW-UHFFFAOYSA-L dipotassium;oxido sulfate Chemical compound [K+].[K+].[O-]OS([O-])(=O)=O JZBWUTVDIDNCMW-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
- GMUXVPNXBVLTCG-UHFFFAOYSA-N ethyl 2-methyl-4-phenyl-1h-imidazole-5-carboxylate Chemical compound N1C(C)=NC(C=2C=CC=CC=2)=C1C(=O)OCC GMUXVPNXBVLTCG-UHFFFAOYSA-N 0.000 description 1
- QYWSSFHUNRWYAW-UHFFFAOYSA-N ethyl 2-methylsulfonyl-4-phenyl-1h-imidazole-5-carboxylate Chemical compound N1C(S(C)(=O)=O)=NC(C=2C=CC=CC=2)=C1C(=O)OCC QYWSSFHUNRWYAW-UHFFFAOYSA-N 0.000 description 1
- KUVOQWRTXPCJOZ-UHFFFAOYSA-N ethyl 2-oxo-4-phenyl-3h-1,3-thiazole-5-carboxylate Chemical compound S1C(=O)NC(C=2C=CC=CC=2)=C1C(=O)OCC KUVOQWRTXPCJOZ-UHFFFAOYSA-N 0.000 description 1
- XBPOBCXHALHJFP-UHFFFAOYSA-N ethyl 4-bromobutanoate Chemical compound CCOC(=O)CCCBr XBPOBCXHALHJFP-UHFFFAOYSA-N 0.000 description 1
- NGMYKWXFKDHMJY-UHFFFAOYSA-N ethyl 5-phenyl-2-sulfanylidene-1,3-dihydroimidazole-4-carboxylate Chemical compound N1C(=S)NC(C=2C=CC=CC=2)=C1C(=O)OCC NGMYKWXFKDHMJY-UHFFFAOYSA-N 0.000 description 1
- IIEWJVIFRVWJOD-UHFFFAOYSA-N ethyl cyclohexane Natural products CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- JKFAIQOWCVVSKC-UHFFFAOYSA-N furazan Chemical compound C=1C=NON=1 JKFAIQOWCVVSKC-UHFFFAOYSA-N 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-M hydroxide;hydrate Chemical compound O.[OH-] JEGUKCSWCFPDGT-UHFFFAOYSA-M 0.000 description 1
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 description 1
- 125000000336 imidazol-5-yl group Chemical group [H]N1C([H])=NC([H])=C1[*] 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- UPAGPWKZSOOAHP-UHFFFAOYSA-N methyl 2-[3-[4-(3-carbamoylphenyl)piperazine-1-carbonyl]-4-phenyl-1h-pyrrol-2-yl]acetate Chemical compound COC(=O)CC=1NC=C(C=2C=CC=CC=2)C=1C(=O)N(CC1)CCN1C1=CC=CC(C(N)=O)=C1 UPAGPWKZSOOAHP-UHFFFAOYSA-N 0.000 description 1
- KQEVIFKPZOGBMZ-UHFFFAOYSA-N methyl 3-bromopropanoate Chemical compound COC(=O)CCBr KQEVIFKPZOGBMZ-UHFFFAOYSA-N 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical compound [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical compound O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 125000001979 organolithium group Chemical group 0.000 description 1
- 125000002734 organomagnesium group Chemical group 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229940080469 phosphocellulose Drugs 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- BYTCDABWEGFPLT-UHFFFAOYSA-L potassium;sodium;dihydroxide Chemical compound [OH-].[OH-].[Na+].[K+] BYTCDABWEGFPLT-UHFFFAOYSA-L 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229940121649 protein inhibitor Drugs 0.000 description 1
- 239000012268 protein inhibitor Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- CSRCBLMBBOJYEX-UHFFFAOYSA-M sodium;2-morpholin-4-ylethanesulfonic acid;hydroxide Chemical compound [OH-].[Na+].OS(=O)(=O)CCN1CCOCC1 CSRCBLMBBOJYEX-UHFFFAOYSA-M 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0306719A FR2855825B1 (fr) | 2003-06-04 | 2003-06-04 | Produits aryl-heteroaromatiques, compositions les contenant et utilisation |
| FR03/06719 | 2003-06-04 | ||
| FR04/04889 | 2004-05-06 | ||
| FR0404889 | 2004-05-06 | ||
| PCT/FR2004/001379 WO2004108685A1 (fr) | 2003-06-04 | 2004-06-03 | Produits aryl-heteroaromatiques, compositions les contenant et utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2528093A1 true CA2528093A1 (fr) | 2004-12-16 |
Family
ID=33512659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002528093A Abandoned CA2528093A1 (fr) | 2003-06-04 | 2004-06-03 | Produits aryl-heteroaromatiques, compositions les contenant et utilisation |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20050014765A1 (enExample) |
| EP (1) | EP1641765A1 (enExample) |
| JP (1) | JP4805813B2 (enExample) |
| KR (1) | KR20060006850A (enExample) |
| AR (1) | AR044586A1 (enExample) |
| AU (1) | AU2004245269A1 (enExample) |
| BR (1) | BRPI0411001A (enExample) |
| CA (1) | CA2528093A1 (enExample) |
| CL (1) | CL2004001359A1 (enExample) |
| IL (1) | IL172222A0 (enExample) |
| MX (1) | MXPA05012929A (enExample) |
| PA (1) | PA8604401A1 (enExample) |
| PE (1) | PE20050226A1 (enExample) |
| TW (1) | TW200510344A (enExample) |
| UY (1) | UY28350A1 (enExample) |
| WO (1) | WO2004108685A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050119251A1 (en) * | 2001-12-21 | 2005-06-02 | Jian-Min Fu | Nicotinamide derivatives and their use as therapeutic agents |
| JP4958785B2 (ja) * | 2004-09-20 | 2012-06-20 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 複素環誘導体およびステアロイル−ＣｏＡデサチュラーゼインヒビターとしてのそれらの使用 |
| AU2005286790A1 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-CoA-desaturase (SCD) |
| TW200626155A (en) * | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
| CN101084211A (zh) * | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 杂环衍生物及其作为治疗剂的用途 |
| WO2006034441A1 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| AU2005286728A1 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
| CA2580855A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| BRPI0515483A (pt) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase |
| ES2359840T5 (es) * | 2004-09-20 | 2015-03-25 | Xenon Pharmaceuticals Inc. | Derivados de piridina para inhibición de estearoil-CoA-desaturasa humana |
| WO2007130075A1 (en) | 2005-06-03 | 2007-11-15 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| TW200800946A (en) * | 2005-08-15 | 2008-01-01 | Astrazeneca Ab | Substituted piperazines as metabotropic glutamate receptor antagonists |
| EP2009011A1 (en) * | 2006-04-14 | 2008-12-31 | Takeda Pharmaceutical Company Limited | Nitrogen-containing heterocyclic compound |
| DE102006027229A1 (de) * | 2006-06-09 | 2007-12-20 | Grünenthal GmbH | 1,3-Disubstituierte 4-Methyl-1H-pyrrol-2-carbonsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln |
| WO2008089005A2 (en) * | 2007-01-12 | 2008-07-24 | Takeda Pharmaceutical Company Limited | Renin inhibitors |
| US9271962B2 (en) * | 2008-03-17 | 2016-03-01 | Northeastern University | Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors |
| AU2009330821B2 (en) | 2008-12-24 | 2015-06-11 | Bial - Portela & Ca, S.A. | Pharmaceutical compounds |
| KR101297652B1 (ko) * | 2010-11-25 | 2013-08-19 | 한국과학기술연구원 | 항암활성을 지닌 카르보아졸계 화합물 |
| JP6076917B2 (ja) * | 2012-01-25 | 2017-02-08 | 株式会社ヤクルト本社 | ピロール化合物 |
| MY169986A (en) | 2012-06-04 | 2019-06-19 | Idorsia Pharmaceuticals Ltd | Benzimidazole-proline derivatives |
| AR092955A1 (es) | 2012-10-10 | 2015-05-06 | Actelion Pharmaceuticals Ltd | Antagonistas de receptores de orexina los cuales son derivados de [orto bi-(hetero-)aril]-[2-(meta bi-(hetero-)aril)-pirrolidin-1-il]-metanona |
| WO2014141065A1 (en) | 2013-03-12 | 2014-09-18 | Actelion Pharmaceuticals Ltd | Azetidine amide derivatives as orexin receptor antagonists |
| JP6421185B2 (ja) | 2013-12-04 | 2018-11-07 | イドーシア ファーマシューティカルズ リミテッドＩｄｏｒｓｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ | ベンゾイミダゾール−プロリン誘導体の使用 |
| WO2020194326A1 (en) | 2019-03-28 | 2020-10-01 | Council Of Scientific And Industrial Research | Process for the preparation of tapentadol and analogs thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5432696A (en) * | 1995-04-07 | 1996-10-23 | Pharmacopeia, Inc. | Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase |
| US5880128A (en) * | 1996-05-08 | 1999-03-09 | Schering Corporation | Carbonyl piperazinyl and piperidinyl compounds |
| DE10035928A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| DE10035908A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| DE10035927A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| FR2815032B1 (fr) * | 2000-10-10 | 2003-08-08 | Pf Medicament | Nouveaux derives d'aminophenyle piperazine ou d'amino phenyle piperide inhibiteurs de proteines prenyl transferase ainsi que leurs preparations |
| EP1517898A1 (de) * | 2002-06-29 | 2005-03-30 | Zentaris GmbH | Aryl- und heteroarylcarbonylpiperazine und deren verwendung zur behandlung gutartiger und b sartiger tumorerkrankungen |
| WO2004037248A2 (en) * | 2002-10-24 | 2004-05-06 | Carex Sa | Modulation of peroxisome proliferator activated receptors activity |
| GB0228417D0 (en) * | 2002-12-05 | 2003-01-08 | Cancer Rec Tech Ltd | Pyrazole compounds |
-
2004
- 2004-06-02 PE PE2004000556A patent/PE20050226A1/es not_active Application Discontinuation
- 2004-06-02 AR ARP040101890A patent/AR044586A1/es not_active Application Discontinuation
- 2004-06-03 BR BRPI0411001-3A patent/BRPI0411001A/pt not_active IP Right Cessation
- 2004-06-03 KR KR1020057023192A patent/KR20060006850A/ko not_active Ceased
- 2004-06-03 AU AU2004245269A patent/AU2004245269A1/en not_active Abandoned
- 2004-06-03 CA CA002528093A patent/CA2528093A1/fr not_active Abandoned
- 2004-06-03 CL CL200401359A patent/CL2004001359A1/es unknown
- 2004-06-03 WO PCT/FR2004/001379 patent/WO2004108685A1/fr not_active Ceased
- 2004-06-03 US US10/859,740 patent/US20050014765A1/en not_active Abandoned
- 2004-06-03 JP JP2006508355A patent/JP4805813B2/ja not_active Expired - Fee Related
- 2004-06-03 TW TW093115885A patent/TW200510344A/zh unknown
- 2004-06-03 EP EP04767247A patent/EP1641765A1/fr not_active Withdrawn
- 2004-06-03 MX MXPA05012929A patent/MXPA05012929A/es active IP Right Grant
- 2004-06-04 UY UY28350A patent/UY28350A1/es unknown
- 2004-06-04 PA PA20048604401A patent/PA8604401A1/es unknown
-
2005
- 2005-11-28 IL IL172222A patent/IL172222A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1641765A1 (fr) | 2006-04-05 |
| HK1093339A1 (zh) | 2007-03-02 |
| PE20050226A1 (es) | 2005-05-18 |
| AU2004245269A1 (en) | 2004-12-16 |
| MXPA05012929A (es) | 2006-02-28 |
| US20050014765A1 (en) | 2005-01-20 |
| BRPI0411001A (pt) | 2006-07-04 |
| PA8604401A1 (es) | 2004-12-16 |
| CL2004001359A1 (es) | 2005-05-06 |
| AR044586A1 (es) | 2005-09-21 |
| JP2006526596A (ja) | 2006-11-24 |
| UY28350A1 (es) | 2004-12-31 |
| TW200510344A (en) | 2005-03-16 |
| WO2004108685A1 (fr) | 2004-12-16 |
| KR20060006850A (ko) | 2006-01-19 |
| JP4805813B2 (ja) | 2011-11-02 |
| IL172222A0 (en) | 2011-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2528093A1 (fr) | Produits aryl-heteroaromatiques, compositions les contenant et utilisation | |
| JP6861858B2 (ja) | Ｓｓａｏ阻害剤 | |
| FR2857966A1 (fr) | Produits aryl-heteroaromatiques, compositions les contenant et utilisation | |
| EP2094706B1 (fr) | Derives de 2,5-dfflydro-3h-pyrazolo[4,3-c]pyridazin-3-one substitues, leur preparation et leur utilisation comme ligands des recepteurs cb1 des cannabinoides | |
| BR112018002304B1 (pt) | Compostos de derivado de 1,3,4-oxadiazol como inibidor de histona desacetilase 6 e a composição farmacêutica que compreende os mesmos | |
| DE69902754T2 (de) | Heteroaryl-amidinen,-methylamidinen und -guanidinen als protease inhibitoren, insbesondere als urokinase inhibitoren | |
| EP1641758B1 (fr) | Derives de diphenylpyridine, leur preparation et leur application therapeutique | |
| CA2781858C (en) | Modulators of tnf-.alpha. signaling | |
| WO2007119001A2 (fr) | Derives d 'aminomethyl pyridine, leur preparation et leur application en therapeutique | |
| EP2733144B1 (en) | Novel compound having parp inhibitory activity | |
| CA2512243A1 (fr) | Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation | |
| JP7428833B2 (ja) | ヒストン脱アセチル化酵素６阻害剤としての１，３，４－オキサジアゾール誘導体化合物、およびそれを含む医薬組成物 | |
| FR2891828A1 (fr) | Derives de la 1-amino-phtalazine substituee, leur preparation et leur application en therapeutique | |
| JP4422964B2 (ja) | ５員複素環誘導体、その製造法及びその医薬としての使用 | |
| EP1966173B1 (fr) | Derives heterocycliques, leur preparation et leur application en therapeutique. | |
| FR2855825A1 (fr) | Produits aryl-heteroaromatiques, compositions les contenant et utilisation | |
| WO2008099076A2 (fr) | Derives de n-(4-cyano-l h-p yrazol-3 -yl)methylamine substitues, leur preparation et leur application en therapeutique | |
| EP1966167B1 (fr) | Derives diaryltriazolmethylamine, leur preparation et leur application en therapeutique. | |
| WO2003099812A1 (fr) | Derives de phenyl-furane ou de phenyl-thiophene, leur preparation et leur application a titre de medicament | |
| CA2586355A1 (fr) | Derives de 4,7-dioxobenzothiazole-2-carboxamides, leur preparation et leurs applications therapeutiques | |
| FR2921063A1 (fr) | Ligands des recepteurs cannabinoides | |
| FR2943672A1 (fr) | Derives de 3-alcoxy-4,5-diarylthiophene-2-carboxamide,leur preparation et leur application en therapeutique. | |
| JPWO2001036386A1 (ja) | ジピペラジン誘導体を含有する糖尿病治療薬 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |